Medicines containing erlotinib: leaflets and ATC codes

About this active substance

Erlotinib is a medication used in the treatment of certain types of lung cancer and advanced pancreatic cancer. It works by blocking a protein involved in the growth and multiplication of cancer cells, thus helping to slow disease progression.

Erlotinib is administered orally as tablets, once daily, according to the oncologist's instructions. The dose may be adjusted depending on the patient's response to treatment and any side effects.

Side effects may include skin rashes, diarrhea, nausea, fatigue, or, rarely, liver dysfunction and severe allergic reactions. Medical monitoring is necessary throughout the treatment.

Erlotinib is an effective option for patients with advanced lung or pancreatic cancer, offering the chance to prolong survival and improve quality of life.

FOKLEROS 150mg film-coated tablets ALKALOID

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Price

2340.97 RON

List

C2

Prescription

P-RF
ERLOTINIB MYLAN 150mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Price

2340.97 RON

List

C2

Prescription

P-RF
ERLOTINIB ZENTIVA 150mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Price

2340.97 RON

List

C2

Prescription

P-RF
FOKLEROS 100mg film-coated tablets ALKALOID

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Price

1942.18 RON

List

C2

Prescription

P-RF
ERLOTINIB MYLAN 100mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Price

1942.18 RON

List

C2

Prescription

P-RF
ERLOTINIB ZENTIVA 100mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Price

1942.18 RON

List

C2

Prescription

P-RF
ERLOTINIB VIATRIS 50mg film-coated tablets VIATRIS LIMITED

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB VIATRIS 100mg film-coated tablets VIATRIS LIMITED

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB VIATRIS 150mg film-coated tablets VIATRIS LIMITED

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB MYLAN 50mg film-coated tablets VIATRIS LIMITED

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB TERAPIA 100mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB TERAPIA 150mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
VARLOTA 100mg film-coated tablets ALVOGEN

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
VARLOTA 150mg film-coated tablets ALVOGEN

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB GLENMARK 100mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB GLENMARK 150mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB HEATON 100mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB HEATON 150mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB SANDOZ 100mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF
ERLOTINIB SANDOZ 150mg film-coated tablets

Chemical substance: erlotinib

ATC code: L01EB02 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Prescription

P-RF